Načítá se...
Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
The increasing understanding of the molecular biology and the etiopathogenetic mechanisms of asthma helps in identification of numerous phenotypes and endotypes, particularly for severe refractory asthma. For a decade, the only available biologic therapy that met the unmet needs of a specific group...
Uloženo v:
| Vydáno v: | J Asthma Allergy |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587160/ https://ncbi.nlm.nih.gov/pubmed/28919788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S144100 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|